- Home
- ATEX
ATEX
Anterix Inc.
as of 11-13-2026 10:48am EST
Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | WOODLAND PARK |
| Market Cap: | 1.6B | IPO Year: | 2014 |
| Target Price: | $118.00 | AVG Volume (30 days): | 252.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | 891.80 |
| 52 Week Low/High: | $19.47 - $113.00 | Next Earning Date: | 11-10-2026 |
| Revenue: | $6,501,000 | Revenue Growth: | 7.79% |
| Revenue Growth (this year): | 213.26% | Revenue Growth (next year): | -25.53% |
| P/E Ratio: | -328.40 | Index: | |
| Free Cash Flow: | 5.5M | FCF Growth: | N/A |
Stock Insider Trading Activity of Anterix Inc. (ATEX)
Chief Financial Officer
Avg Cost/Share
$81.32
Shares
4,981
Total Value
$400,606.80
Owned After
13,104
President and CEO
Avg Cost/Share
$80.00
Shares
15,000
Total Value
$1,200,000.00
Owned After
26,470
SEC Form 4
Chief Legal Officer & Corp Sec
Avg Cost/Share
$85.44
Shares
4,357
Total Value
$372,262.08
Owned After
9,238
Director
Avg Cost/Share
$86.91
Shares
4,100
Total Value
$356,999.87
Owned After
47,177
Director
Avg Cost/Share
$87.15
Shares
6,000
Total Value
$522,900.00
Owned After
47,177
SEC Form 4
Chief Reg & Comm Officer
Avg Cost/Share
$92.16
Shares
23,439
Total Value
$2,164,837.18
Owned After
47,572
Director, Other
Avg Cost/Share
$89.58
Shares
10,000
Total Value
$888,526.47
Owned After
18,921
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Marquez Elena | ATEX | Chief Financial Officer | Oct 9, 2026 | Sell | $81.32 | 4,981 | $400,606.80 | 13,104 | |
| Lang Scott A. | ATEX | President and CEO | Sep 21, 2026 | Sell | $80.00 | 15,000 | $1,200,000.00 | 26,470 | |
| Ashe Gena L | ATEX | Chief Legal Officer & Corp Sec | Sep 8, 2026 | Sell | $85.44 | 4,357 | $372,262.08 | 9,238 | |
| DANIELS LESLIE B | ATEX | Director | Sep 4, 2026 | Sell | $86.91 | 4,100 | $356,999.87 | 47,177 | |
| DANIELS LESLIE B | ATEX | Director | Sep 3, 2026 | Sell | $87.15 | 6,000 | $522,900.00 | 47,177 | |
| Guttman-McCabe Christopher | ATEX | Chief Reg & Comm Officer | Aug 25, 2026 | Sell | $92.16 | 23,439 | $2,164,837.18 | 47,572 | |
| Kuhn Thomas R. | ATEX | Director, Other | Aug 24, 2026 | Sell | $89.58 | 10,000 | $888,526.47 | 18,921 |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q3 Q3 2026 Earnings
8-K SELL Nov 10, 2026 · 100% conf.
Q3 2026 Earnings
8-K SELLNov 10, 2026 · 100% conf.
1D
-3.48%
$72.84
Act: -0.23%
5D
-4.17%
$72.32
20D
-10.61%
$67.46
atex-20261110
0001304492FALSE00013044922026-11-102026-11-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2026
Anterix Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3682733-0745043
(State or other jurisdiction (Commission File Number)(IRS Employer
of incorporation)Identification No.)
3 Garret Mountain Plaza
Suite 40107424
Woodland Park, NJ
(Address of principal executive offices)(Zip Code)
(973) 771-0300
Registrant’s telephone number, including area code
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12(b))
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par valueATEX The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 10, 2026, Anterix Inc. (the “Company”) issued an Earnings Release announcing its second quarter fiscal 2027 financial results for the three and six months ended September 30, 2026. A copy of the Earnings Release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Current Report and in Exhibit 99.1 of Item 9.01 below is being “furnished” pursuant to Item 2.02 of Form 8-K, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Accordingly, the information in Item 2.02 will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or under the Exchange Act, unless specifically identified therein as being incorporated therein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.Description
99.1
Anterix Inc. Earnings Release, dated November 10, 2026.
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Anterix Inc.
Date: November 10, 2026 /s/ Elena Marquez
Elena Marquez
Chief Financial Officer
2026 Q2 Q2 2026 Earnings
8-K BUY Aug 11, 2026 · 100% conf.
Q2 2026 Earnings
8-K BUYAug 11, 2026 · 100% conf.
1D
+10.00%
$102.23
Act: -4.45%
5D
+16.87%
$108.62
20D
+22.71%
$114.04
atex-20260811
0001304492FALSE00013044922025-08-122025-08-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 11, 2026
Anterix Inc.
(Exact name of registrant as specified in its charter)
Delaware001-3682733-0745043
(State or other jurisdiction (Commission File Number)(IRS Employer
of incorporation)Identification No.)
3 Garret Mountain Plaza
Suite 40107424
Woodland Park, NJ
(Address of principal executive offices)(Zip Code)
(973) 771-0300
Registrant’s telephone number, including area code
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12(b))
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par valueATEX The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 11, 2026, Anterix Inc. (the “Company”) issued an Earnings Release announcing its first quarter fiscal 2027 financial results for the three months ended June 30, 2026. A copy of the Earnings Release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Current Report and in Exhibit 99.1 of Item 9.01 below is being “furnished” pursuant to Item 2.02 of Form 8-K, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Accordingly, the information in Item 2.02 will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or under the Exchange Act, unless specifically identified therein as being incorporated therein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.Description
99.1
Anterix Inc. Earnings Release, dated August 11, 2026.
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Anterix Inc.
Date: August 11, 2026 /s/ Elena Marquez
Elena Marquez
Chief Financial Officer
2026 Q1 Q1 2026 Earnings
8-K BUY Jun 10, 2026 · 100% conf.
Q1 2026 Earnings
8-K BUYJun 10, 2026 · 100% conf.
1D
+7.94%
$69.92
Act: +24.44%
5D
+16.11%
$75.21
Act: +22.20%
20D
+17.97%
$76.42
Act: +55.85%
atex-20260610
0001304492FALSE00013044922026-06-102026-06-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 10, 2026
Anterix Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-36827 33-0745043
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
3 Garret Mountain Plaza
Suite 40107424
Woodland Park, NJ
(Address of principal executive offices) (Zip Code)
(973) 771-0300
Registrant’s telephone number, including area code
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12(b))
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par valueATEX The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On June 10, 2026, Anterix Inc. (the “Company”) issued an Earnings Release announcing its Fiscal 2026 fourth quarter and year-end financial results for the quarter and year ended March 31, 2026. A copy of the Earnings Release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Current Report and in Exhibits 99.1 of Item 9.01 below is being “furnished” pursuant to Item 2.02 of Form 8-K, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Accordingly, the information in Item 2.02 will not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or under the Exchange Act, unless specifically identified therein as being incorporated therein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.Description
99.1
Anterix Inc. Earnings Release, dated June 10, 2026.
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Anterix Inc.
Date: June 10, 2026 /s/ Elena Marquez
Elena Marquez
Chief Financial Officer
Compare ATEX vs Leading Stocks
See how ATEX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ATEX Anterix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.